Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Development and Validation of a Risk Prediction Model for New-Onset Diabetes After Pancreatectomy

NCT07436273 is registered in ClinicalTrials.gov with Ningbo No. 1 Hospital as lead sponsor.

NCT NCT07436273
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07436273 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Development and Validation of a Risk Prediction Model for New-Onset Diabetes After Pancreatectomy
Lead sponsor
Ningbo No. 1 Hospital
Phase
Observational
Overall status
Completed
Start date
June 1, 2023
Completion date
June 30, 2025
Enrollment
575 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

identification of influencing factors and construction of a prediction model for new-onset diabetes after pancreatectomy